UCP2 and pulmonary arterial hypertension: Interestingly, loss-of-function genetic variant of UCP2 in pulmonary arterial hypertensive patients causes resistance to PDK inhibitors, due to the regulation of PDH (the downstream target of PDK) by UCP2-dependent mitochondrial calcium homeostasis (Michelakis et al., 2017).